LONG-LASTING PROLACTIN-LOWERING EFFECT OF CABERGOLINE, A NEW DOPAMINE AGONIST, IN HYPERPROLACTINEMIC PATIENTS

被引：112

作者：

FERRARI, C ^{[1
]}

BARBIERI, C

CALDARA, R

MUCCI, M

CODECASA, F

PARACCHI, A

ROMANO, C

BOGHEN, M

DUBINI, A

机构：

[1] FATEBENEFRATELLI HOSP, DEPT MED 2, I-20121 MILAN, ITALY

[2] FARMITALIA CARLO ERBA SPA RES & DEV, DEPT CLIN RES, MILAN, ITALY

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1986年 / 63卷 / 04期

关键词：

D O I：

10.1210/jcem-63-4-941

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：941 / 945

页数：5

共 10 条

[1] EFFECT OF THE NEW ERGOT DERIVATIVE TERGURIDE ON PLASMA PRL AND GH LEVELS IN PATIENTS WITH PATHOLOGICAL HYPERPROLACTINEMIA OR ACROMEGALY [J].

DALLABONZANA, D ;

LIUZZI, A ;

OPPIZZI, G ;

VERDE, G ;

CHIODINI, PG ;

DOROW, R ;

HOROWSKI, R .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1985, 8 (02) :147-151

[2]

DISALLE E, 1983, ACTA ENDOCR-COP S256, V103, P265

[3]

DISALLE E, 1984, J ENDOCRINOL INVE S1, V7, P32

[4]

Ferrari C., 1982, Hormone antagonists, P503

[5]

FERRARI C, 1983, ACTA ENDOCRINOL-COP, V103, P1

[6] EFFECT OF DIHYDROERGOKRYPTINE ADMINISTRATION ON SERUM PROLACTIN AND GROWTH-HORMONE LEVELS IN NORMAL, HYPERPROLACTINAEMIC AND ACROMEGALIC SUBJECTS - EVIDENCE OF POTENT AND LONG-LASTING PITUITARY DOPAMINE RECEPTOR STIMULATION [J].

FERRARI, C ;

RAMPINI, P ;

PARACCHI, A ;

BOGHEN, M ;

MAILLAND, F .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 27 (06) :707-711

[7]

GILL JL, 1978, DESIGN ANAL EXPT ANI, P29

[8] COMPARISON OF THE CLINICAL ACTIVITY OF MESULERGINE AND PERGOLIDE IN THE TREATMENT OF HYPERPROLACTINEMIA [J].

GROSSMAN, A ;

BOULOUX, PMG ;

LONERAGAN, R ;

REES, LH ;

WASS, JAH ;

BESSER, GM .

CLINICAL ENDOCRINOLOGY, 1985, 22 (05) :611-616

[9] POTENT 48 HOURS INHIBITION OF PROLACTIN SECRETION BY PERGOLIDE IN HYPERPROLACTINEMIC WOMEN [J].

LHERMITE, M ;

DEBUSSCHERE, P .

ACTA ENDOCRINOLOGICA, 1982, 101 (04) :481-483

[10]

PONTIROLI A E, 1985, Journal of Endocrinological Investigation, V8, P103

← 1 →